Third, diminished muscle quantity and quality in sarcopenic obesity reduces secretion of beneficial myokines including irisin, interleukin-15, and insulin-like growth factor-1, which ordinarily provide cardioprotection through local and systemic signaling mechanisms [37,38]. Here, IGF1 is linked to obesity disorder.